Protagenic Therapeutics- Warrants (13/04/2025) Other Current Liabilities

The latest other current liabilities for PTIXW is $1.6M as of December 2025. That compares with $840K in the prior-year period — up 95.0% year over year. Investors often review this figure alongside Protagenic Therapeutics- Warrants (13/04/2025)'s historical trend and sector peers before judging valuation or financial health.

Over the past year, PTIXW's other current liabilities moved from $840K to $1.6M — a 95.0% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Protagenic Therapeutics- Warrants (13/04/2025)'s operating scale or balance-sheet position.

A other current liabilities figure of $1.6M for PTIXW is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting PTIXW's other current liabilities ($1.6M), review year-over-year change from $840K, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

This page's peer comparison chart is the fastest way to stack Protagenic Therapeutics- Warrants (13/04/2025)'s other current liabilities against similar Industrials names. You can also browse sector and industry screens on Stockcircle for a broader set of Industrials companies and their key multiples and fundamentals.